effects of a multicomponent exercise program incorporating waltz dance on postmenopausal women with dyslipidemia: a randomized controlled trial

Conditions: Dyslipaemia

Summary: brief summary: the goal of this clinical trial is to evaluate whether a 12-week multicomponent exercise program-combining waltz dance, resistance training, and agility training-can improve physiological, psychological, and cognitive outcomes in postmenopausal women aged ≤65 years with dyslipidemia. the main research questions are: does the intervention reduce blood lipid levels (e.g., total cholesterol, triglycerides) and improve body composition (e.g., fat percentage, lean muscle mass)? does the intervention enhance cardiovascular fitness, balance, mental well-being, and cognitive function, compared to a no-exercise control group? researchers will compare outcomes between an exercise intervention group and a non-exercise control group to assess the program's effectiveness. study procedures: participants will: engage in supervised exercise sessions 3 times per week for 12 weeks (each session lasting \~90 minutes). participate in: * .waltz dance training (basic steps and choreographed routines), * resistance band exercises (targeting major muscle groups), * agility and balance training modules complete pre- and post-intervention assessments, including: * blood lipid profiles, * body composition analysis, * cardiovascular fitness and balance tests, * standardized mental health and cognitive assessments.


Eligibility criteria:
inclusion criteria: 1. age: postmenopausal women aged ≤65 years at the time of enrollment. 2. menopausal status: natural menopause defined as spontaneous cessation of menstruation for ≥12 consecutive months, excluding menopause due to pathological or surgical causes (e.g., oophorectomy, thyroid disorders). 3. dyslipidemia: presence of one or more of the following lipid abnormalities: high-density lipoprotein cholesterol (hdl-c) \< 1.04 mmol/l triglycerides (tg) ≥ 1.7 mmol/l low-density lipoprotein cholesterol (ldl-c) ≥ 3.0 mmol/l total cholesterol (tc) ≥ 5.18 mmol/l 4. obesity or sarcopenic tendency: body fat percentage \> 30%, as measured by validated body composition analyzer. 5. physical capability: no musculoskeletal injuries, physical disabilities, or contraindications to exercise. participants must be cleared using the physical activity readiness questionnaire (par-q). 6. sedentary lifestyle: engaging in structured physical activity ≤3 times per week, with each session lasting ≤20 minutes, in the last 6 months. 7. no recent weight control interventions: no use of weight-loss supplements or engagement in intentional weight loss through diet or exercise in the past year. 8. voluntary participation: willingness to participate in the study and provide written informed consent (informed consent form, icf). exclusion criteria: 1. metabolic or endocrine disorders: history of insulin-dependent diabetes mellitus, untreated or unstable thyroid dysfunction, cushing's syndrome, or other serious endocrine diseases. 2. cardiovascular disease: uncontrolled hypertension, arrhythmias, congestive heart failure, or a history of myocardial infarction or stroke within the past 6 months. 3. severe respiratory conditions: chronic obstructive pulmonary disease (copd), pulmonary fibrosis, or any condition significantly limiting exercise tolerance. 4. neurological disorders: parkinson's disease, post-stroke sequelae, moderate to severe cognitive impairment, or alzheimer's disease. 5. inflammatory or autoimmune diseases: active rheumatoid arthritis, crohn's disease, or other chronic inflammatory conditions. 6. cancer: diagnosis of any malignancy within the past 5 years. 7. musculoskeletal limitations: diagnosed severe osteoporosis or a history of falls or fractures within the past 6 months. 8. extremes of body mass index (bmi): bmi ≥35 kg/m² or \<18.5 kg/m². 9. substance use: current drug abuse, heavy alcohol consumption (defined as \>70 g alcohol/week), or heavy smoking (≥10 cigarettes/day) that cannot be reduced during the study period. 10. dietary extremes: strict vegetarian, ketogenic, or other extreme dietary patterns that may affect metabolic outcomes. 11. medications: current hormone replacement therapy (e.g., estrogen, testosterone). use of antidepressants in the past 6 months. regular use of medications affecting lipid metabolism, bone health, or cardiovascular function (e.g., aspirin, statins, antihypertensive or antidiabetic drugs). 12. recent structured exercise: participation in structured dance, resistance, or agility training within the past 12 months.

Keywords: dyslipaemia multicomponent exercise postmenopausal women waltz